Skip to content
10-K

Annual Report

FENNEC PHARMACEUTICALS INC. FENC

0001104659-26-036182

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 20, 2026 34.48M sh
Shares Diluted FY 2025 · Dec 31, 2025 28.58M sh
Shares Diluted FY 2025 · Dec 31, 2024 27.29M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$12.47M
Operating Cash Flow FY 2025 · Dec 31, 2024 $26.98M
Cash And Equivalents FY 2025 · Dec 31, 2025 $36.79M
Cash And Equivalents FY 2025 · Dec 31, 2024 $26.63M
Stockholders Equity FY 2025 · Dec 31, 2025 $35.47M
Stockholders Equity FY 2025 · Dec 31, 2024 −$5.87M
Stockholders Equity FY 2025 · Dec 31, 2023 −$11.62M
Current Liabilities FY 2025 · Dec 31, 2025 $10.52M
Current Liabilities FY 2025 · Dec 31, 2024 $6.92M
Total Liabilities FY 2025 · Dec 31, 2025 $35.08M
Total Liabilities FY 2025 · Dec 31, 2024 $50.82M
Current Assets FY 2025 · Dec 31, 2025 $67.04M
Current Assets FY 2025 · Dec 31, 2024 $44.12M
Total Assets FY 2025 · Dec 31, 2025 $70.55M
Total Assets FY 2025 · Dec 31, 2024 $44.95M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.34
Eps Diluted FY 2025 · Dec 31, 2024 −$0.02
Eps Basic FY 2025 · Dec 31, 2025 −$0.34
Eps Basic FY 2025 · Dec 31, 2024 −$0.02
Sga Expense FY 2025 · Dec 31, 2025 $28.29M
Sga Expense FY 2025 · Dec 31, 2024 $23.05M
Rd Expense FY 2025 · Dec 31, 2025 $250K
Rd Expense FY 2025 · Dec 31, 2024 $307K
Net Income FY 2025 · Dec 31, 2025 −$9.74M
Net Income FY 2025 · Dec 31, 2024 −$436K
Operating Income FY 2025 · Dec 31, 2025 −$6.28M
Operating Income FY 2025 · Dec 31, 2024 $2.57M
Revenue FY 2025 · Dec 31, 2025 $44.64M
Revenue FY 2025 · Dec 31, 2024 $47.54M